Physician profile
Jack W Moore
NPI 1235170812
$3,880.11
in general payments reported to CMS, 2019-2025
13 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $193 · 2021: $1,560 · 2022: $402 · 2023: $373 · 2024: $580 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $1,720.55 | 2019-2024 | |
| Stryker Corporation | $674.31 | 2019-2021 | |
| Depuy Synthes Sales INC. | $450.02 | 2021-2025 | Na, Va-Lcp, Fibulink |
| Smith+Nephew, INC. | $307.63 | 2020-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Linvatec Corporation | $174.99 | 2024 | Biobrace 23mm |
| Arthrex, INC. | $160.05 | 2023-2024 | Knee & Hip Implants Suspensory Fixation Acl Tightrope, Distal Extremities Implants Trauma |
| Medical Device Business Services, INC. | $109.65 | 2022 | |
| Sanofi-Aventis U.S. LLC | $100.87 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $43.73 | 2024 | Iovera, Zilretta |
| Pacira Therapeutics, INC. | $39.59 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $37.65 | 2022 | |
| Boston Scientific Corporation | $35.00 | 2025 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $26.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.